These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11555700)

  • 1. Homocysteine, vitamins and gene mutations in peripheral arterial disease.
    Stricker H; Soldati G; Balmelli T; Mombelli G
    Blood Coagul Fibrinolysis; 2001 Sep; 12(6):469-75. PubMed ID: 11555700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
    Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
    Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
    Födinger M; Mannhalter C; Wölfl G; Pabinger I; Müller E; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1997 Aug; 52(2):517-23. PubMed ID: 9264011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease.
    Rassoul F; Richter V; Janke C; Purschwitz K; Klötzer B; Geisel J; Herrmann W
    Angiology; 2000 Mar; 51(3):189-96. PubMed ID: 10744006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects.
    Gemmati D; Previati M; Serino ML; Moratelli S; Guerra S; Capitani S; Forini E; Ballerini G; Scapoli GL
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1761-7. PubMed ID: 10397696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.
    Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Perschl A; Vychytil A; Hörl WH; Sunder-Plassmann G
    Am J Kidney Dis; 2001 Jul; 38(1):77-84. PubMed ID: 11431185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
    de Jong SC; Stehouwer CD; van den Berg M; Kostense PJ; Alders D; Jakobs C; Pals G; Rauwerda JA
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1316-24. PubMed ID: 10323785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study.
    Dekou V; Whincup P; Papacosta O; Ebrahim S; Lennon L; Ueland PM; Refsum H; Humphries SE; Gudnason V
    Atherosclerosis; 2001 Feb; 154(3):659-66. PubMed ID: 11257267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis.
    Verhoeff BJ; Trip MD; Prins MH; Kastelein JJ; Reitsma PH
    Atherosclerosis; 1998 Nov; 141(1):161-6. PubMed ID: 9863549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Homocysteine, Serum Folic Acid, Serum Vitamin B12, Serum Vitamin B6, MTHFR, and Risk of Normal-Tension Glaucoma.
    Li J; Xu F; Zeng R; Gong H; Lan Y
    J Glaucoma; 2016 Feb; 25(2):e94-8. PubMed ID: 26171850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.
    Verhoef P; Kok FJ; Kluijtmans LA; Blom HJ; Refsum H; Ueland PM; Kruyssen DA
    Atherosclerosis; 1997 Jul; 132(1):105-13. PubMed ID: 9247365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease.
    Cahill MT; Stinnett SS; Fekrat S
    Am J Ophthalmol; 2003 Dec; 136(6):1136-50. PubMed ID: 14644226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels.
    Feix A; Fritsche-Polanz R; Kletzmayr J; Vychytil A; Hörl WH; Sunder-Plassmann G; Födinger M
    Am J Kidney Dis; 2001 Nov; 38(5):956-64. PubMed ID: 11684547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay.
    Herrmann W; Obeid R; Schorr H; Zarzour W; Geisel J
    Clin Chem Lab Med; 2003 Apr; 41(4):547-53. PubMed ID: 12747601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
    Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene.
    Schwartz SM; Siscovick DS; Malinow MR; Rosendaal FR; Beverly RK; Hess DL; Psaty BM; Longstreth WT; Koepsell TD; Raghunathan TE; Reitsma PH
    Circulation; 1997 Jul; 96(2):412-7. PubMed ID: 9244205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.